Ginkgo Bioworks grants RSUs to major shareholder
Canton Barry reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Canton Barry reported acquisition or exercise transactions in this Form 4 filing.
Ginkgo Bioworks Holdings, Inc. reported that ten percent owner Barry Canton received four restricted stock unit awards on July 28, 2026, covering a total of 319,332 RSUs tied to Class A Common Stock. Two grants are held directly and two indirectly via his spouse, with portions vesting 75% on October 16, 2026 and 25% on January 21, 2027, and others vesting in equal quarterly installments over 12 quarters starting October 16, 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F1, F2 | 35,736 | -- | -- |
| Grant/Award | Restricted Stock Units F1, F3 | 117,135 | -- | -- |
| Grant/Award | Restricted Stock Units F1, F2 | 39,038 | -- | -- |
| Grant/Award | Restricted Stock Units F1, F3 | 127,423 | -- | -- |
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.
- F3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.
Key Figures
Key Terms
Restricted Stock Units financial
Class A Common Stock financial
ten percent owner regulatory
Compensation Committee regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Barry Canton report for Ginkgo Bioworks (DNA)?
How many Ginkgo Bioworks (DNA) RSUs vest on near-term dates for Barry Canton?
What is the long-term RSU vesting schedule for Barry Canton at Ginkgo Bioworks (DNA)?
Are Barry Canton's Ginkgo Bioworks (DNA) RSU grants direct or indirect holdings?
What does each RSU reported by Barry Canton in Ginkgo Bioworks (DNA) represent?
AI-generated analysis. How Rhea-AI works. Not financial advice.